Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4282)
All Articles published online
|
Jun 7, 2009 (publication date) through May 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Piao YF, Jiang Z, Chen L, Sun HB. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice. World J Gastroenterol 2009; 15(21): 2602-2608 [PMID: 19496189 DOI: 10.3748/wjg.15.2602] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i21/2602.htm |
| Number | Citing Articles |
| 1 |
Yizi Li, Manlin Tian, Jaceline Gislaine Pires Sanches, Qingqing Zhang, Li Hou, Jun Zhang. Sorcin Inhibits Mitochondrial Apoptosis by Interacting with STAT3 via NF-κB Pathway. International Journal of Molecular Sciences 2024; 25(13): 7206 doi: 10.3390/ijms25137206
|
| 2 |
Roxane Paulin, Jolyane Meloche, Sébastien Bonnet. STAT3 signaling in pulmonary arterial hypertension. JAK-STAT 2012; 1(4): 223 doi: 10.4161/jkst.22366
|
| 3 |
Nathália Alves Araújo de Almeida, Camilla Rodrigues de Almeida Ribeiro, Jéssica Vasques Raposo, Vanessa Salete de Paula. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review. Viruses 2021; 13(5): 822 doi: 10.3390/v13050822
|
| 4 |
Zhenggang Chen, Shaohua Liu, Tomoki Sumida, Shanzhen Sun, Yuan Wei, Meng Liu, Zuoqing Dong, Fan Zhang, Hiroyuki Hamakawa, Fengcai Wei. Silencing Id-1 with RNA Interference Inhibits Adenoid Cystic Carcinoma in Mice. Journal of Surgical Research 2011; 169(1): 57 doi: 10.1016/j.jss.2009.11.723
|
| 5 |
Wolfgang Glienke, Eva Hausmann, Lothar Bergmann. Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines. Tumor Biology 2011; 32(3): 493 doi: 10.1007/s13277-010-0143-4
|
| 6 |
Veronika Caisová, Ondřej Uher, Pavla Nedbalová, Ivana Jochmanová, Karolína Kvardová, Kamila Masáková, Gabriela Krejčová, Lucie Paďouková, Jindřich Chmelař, Jan Kopecký, Jan Ženka. Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis. International Immunopharmacology 2018; 59: 86 doi: 10.1016/j.intimp.2018.03.038
|
| 7 |
Veronika Caisova, Liping Li, Garima Gupta, Ivana Jochmanova, Abhishek Jha, Ondrej Uher, Thanh-Truc Huynh, Markku Miettinen, Ying Pang, Luma Abunimer, Gang Niu, Xiaoyuan Chen, Hans Kumar Ghayee, David Taïeb, Zhengping Zhuang, Jan Zenka, Karel Pacak. The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40. Cancers 2019; 11(5): 654 doi: 10.3390/cancers11050654
|
| 8 |
Kavita Ramji, Dorota Weronika Kulesza, Salem Chouaib, Bozena Kaminska. Off-target effects of plasmid-transcribed shRNAs on NFκB signaling pathway and cell survival of human melanoma cells. Molecular Biology Reports 2013; 40(12): 6977 doi: 10.1007/s11033-013-2817-7
|
| 9 |
Yan Liu, Jiayuh Lin. Blocking the IL-6–STAT3 Signaling Pathway: Potential Liver Cancer Therapy. Future Oncology 2011; 7(2): 161 doi: 10.2217/fon.10.183
|
| 10 |
Khalil Hajiasgharzadeh, Mohammad Hossein Somi, Dariush Shanehbandi, Ahad Mokhtarzadeh, Behzad Baradaran. Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(4): 3263 doi: 10.1002/jcp.27015
|
| 11 |
S Marozin, J Altomonte, K A Muñoz-Álvarez, A Rizzani, E N De Toni, W E Thasler, R M Schmid, O Ebert. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma. Cancer Gene Therapy 2015; 22(6): 317 doi: 10.1038/cgt.2015.23
|
| 12 |
Veronika Caisová, Andra Vieru, Zuzana Kumžáková, Simona Glaserová, Hana Husníková, Nikol Vácová, Gabriela Krejčová, Lucie Paďouková, Ivana Jochmanová, Katherine I. Wolf, Jindřich Chmelař, Jan Kopecký, Jan Ženka. Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2982-x
|
| 13 |
Connor Phalon, Donald D. Rao, John Nemunaitis. Potential use of RNA interference in cancer therapy. Expert Reviews in Molecular Medicine 2010; 12 doi: 10.1017/S1462399410001584
|
| 14 |
Dorota W. Kulesza, Thibault Carré, Salem Chouaib, Bozena Kaminska. Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity. Experimental Cell Research 2013; 319(4): 506 doi: 10.1016/j.yexcr.2012.11.005
|
| 15 |
JUN YAN, QIANLIANG WANG, KANG ZOU, LI WANG, ERIC B SCHWARTZ, JAMES R FUCHS, ZUGEN ZHENG, JIANQIANG WU. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma. Molecular Medicine Reports 2015; 12(1): 498 doi: 10.3892/mmr.2015.3439
|
| 16 |
Dorota W. Kulesza, Kavita Ramji, Marta Maleszewska, Jakub Mieczkowski, Michal Dabrowski, Salem Chouaib, Bozena Kaminska. Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells. Laboratory Investigation 2019; 99(11): 1607 doi: 10.1038/s41374-019-0288-8
|
| 17 |
Yan Liu, Aiguo Liu, Zhenghu Xu, Wenying Yu, Hong Wang, Chenglong Li, Jiayuh Lin. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells. Apoptosis 2011; 16(5): 502 doi: 10.1007/s10495-011-0578-0
|
| 18 |
Eva Waldmannová, Veronika Caisová, Julie Fáberová, Petra Sváčková, Markéta Kovářová, Denisa Sváčková, Zuzana Kumžáková, Adéla Jačková, Nikol Vácová, Pavla Nedbalová, Marie Horká, Jan Kopecký, Jan Ženka. The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model. International Immunopharmacology 2016; 39: 295 doi: 10.1016/j.intimp.2016.08.004
|
| 19 |
Vivek B Mathema, Wanna Chaijaroenkul, Kesara Na-Bangchang. Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells. Journal of Pharmacy and Pharmacology 2019; 71(2): 185 doi: 10.1111/jphp.13024
|
| 20 |
Vivek B Mathema, Wanna Chaijaroenkul, Juntra Karbwang, Kesara Na‐Bangchang. Growth inhibitory effect of β‐eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase‐1 production, STAT1/3 activation, and NF‐κB downregulation. Clinical and Experimental Pharmacology and Physiology 2017; 44(11): 1145 doi: 10.1111/1440-1681.12818
|
| 21 |
W.F. Qian, W.X. Guan, Y. Gao, J.F. Tan, Z.M. Qiao, H. Huang, C.L. Xia. Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma. Brazilian Journal of Medical and Biological Research 2011; 44(12): 1222 doi: 10.1590/S0100-879X2011007500143
|
| 22 |
Andrea Frejlachova, Radka Lencova, Anna Venhauerova, Marketa Skalickova, Ondrej Uher, Veronika Caisova, Pavel Majer, Lukas Tenora, Per Hansen, Jindrich Chmelar, Jan Kopecky, Zhengping Zhuang, Karel Pacak, Jan Zenka. The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma. International Immunopharmacology 2023; 118: 110150 doi: 10.1016/j.intimp.2023.110150
|
| 23 |
Nermin M. Mohamed, Rania Hassan Mohamed, John F. Kennedy, Mahmoud M. Elhefnawi, Nadia M. Hamdy. A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. International Journal of Biological Macromolecules 2025; 311: 143616 doi: 10.1016/j.ijbiomac.2025.143616
|
| 24 |
Tereza Janotová, Marie Jalovecká, Marie Auerová, Ivana Švecová, Pavlína Bruzlová, Veronika Maierová, Zuzana Kumžáková, Štěpánka Čunátová, Zuzana Vlčková, Veronika Caisová, Petra Rozsypalová, Katarína Lukáčová, Nikol Vácová, Markéta Wachtlová, Jiří Salát, Jaroslava Lieskovská, Jan Kopecký, Jan Ženka, Lucia Gabriele. The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model. PLoS ONE 2014; 9(1): e85222 doi: 10.1371/journal.pone.0085222
|
| 25 |
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Alan P. Kumar, Benny K. H. Tan, Gautam Sethi. Perspectives in Cancer Prevention-Translational Cancer Research. 2014; : 73 doi: 10.1007/978-81-322-1533-2_6
|
| 26 |
Ondrej Uher, Veronika Caisova, Lucie Padoukova, Karolina Kvardova, Kamila Masakova, Radka Lencova, Andrea Frejlachova, Marketa Skalickova, Anna Venhauerova, Adela Chlastakova, Per Hansen, Jindrich Chmelar, Jan Kopecky, Zhengping Zhuang, Karel Pacak, Jan Zenka. Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations. Cancer Immunology, Immunotherapy 2021; 70(11): 3303 doi: 10.1007/s00262-021-02920-9
|
| 27 |
Roxane Paulin, Jolyane Meloche, Maria Helena Jacob, Malik Bisserier, Audrey Courboulin, Sébastien Bonnet. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2011; 301(5): H1798 doi: 10.1152/ajpheart.00654.2011
|